Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.19
-0.55 (-4.32%)
At close: Oct 29, 2025, 4:00 PM EDT
12.01
-0.18 (-1.48%)
After-hours: Oct 29, 2025, 7:55 PM EDT

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $49.60M in the quarter ending June 30, 2025, a decrease of -11.75%. This brings the company's revenue in the last twelve months to $230.82M, up 25.21% year-over-year. In the year 2024, Ginkgo Bioworks Holdings had annual revenue of $227.04M, down -9.71%.

Revenue (ttm)
$230.82M
Revenue Growth
+25.21%
P/S Ratio
2.84
Revenue / Employee
$276,757
Employees
834
Market Cap
675.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings